无约束度作为一个,以驱动个性化补充
D Metsu1, C Cinq-Frais2, C Camare3
1Department of Clinical Laboratory, Montauban Hospital, Montauban, France; Institute of Metabolic and Cardiovascular Diseases (I2MC), Equipe MetaDiab, University of Toulouse, INSERM, University of Toulouse III - Paul Sabatier (UPS), Toulouse, France.
Clinical nutrition (Edinburgh, Scotland)
|March 21, 2024
概括
监测总和未结合的 (Zn) 水平对于个性化补充至关重要. 这种方法通过准确评估状况,改善了患者的护理,特别是在危急条件下.
科学领域:
- 临床化学 临床化学
- 营养科学 营养科学
- 药理动力学 药理动力学
背景情况:
- (Zn) 量化对于管理炎症性疾病和重症监护等临床疾病至关重要.
- 目前对Zn状况的评估依赖于血/血清度,其中包括未结合的Zn (Zn-Cu) 和结合白蛋白的Zn (Zn-Cb).
研究的目的:
- 引入一种药理动力学方法来解释总度 (Zn-Ct).
- 通过考虑Zn-Cu和低albuminemia对Zn-Cb的影响来增强补充策略的个性化.
主要方法:
- 使用药理动力学模型分析总度 (Zn-Ct).
- 考虑未结合的 (Zn-Cu) 和低蛋白水平对结合 (Zn-Cb) 的影响.
主要成果:
- 在某些情况下,如怀孕或特定的炎症性疾病,可能不需要补充.
- 在重症监护环境中,测量未结合的 (Zn-Cu) 更适合于优化补充.
结论:
- 对于个性化补充,建议监测总和未结合的含量.
- 这种双重监测方法有助于根据个体患者的需要量身定制疗法.
相关概念视频
EDTA: Auxiliary Complexing Reagents
586
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
586
Drug Distribution: Plasma Protein Binding
5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Extraction: Advanced Methods
446
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
446
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Drug Concentrations: Measurements
370
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
370


